Antibodies or antibody-fragments thereof targeting alphaviruses, and compositions and methods comprising same
US12186383B2 · kind B2 · utility
0Cited by
1References
26Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 6, 2019 |
| Grant date | Jan 7, 2025 |
| Priority date | — |
| Expiry date | Mar 13, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Provided are high affinity anti-alphavirus antibodies or alphavirus-binding fragments thereof, as well as methods of use and devices employing such antibodies and/or fragments. Further provided are complementarity determining region (CDR) sequences of variable domain light chain (VL) and variable domain heavy chain (VH) sequences, and the methods of using the high affinity anti-alphavirus antibodies for treating different types of alphavirus infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.